Advanced search    

Search: authors:"Jo Ann LeQuang"

6 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Three Years Down the Road: The Aftermath of the CDC Guideline for Prescribing Opioids for Chronic Pain

for the integrity of the work as a whole, and have given their approval for this version to be published. Disclosures Joseph V. Pergolizzi, Jr., Melanie Rosenblatt, and Jo Ann LeQuang have nothing to

Poppy Seed Tea: A Short Review and Case Study

whole, and have given their approval for this version to be published. Disclosures Joseph Pergolizzi Jr., Irving Haber, and Jo Ann LeQuang have nothing to disclose. Compliance with Ethics Guidelines

The Role of Lofexidine in Management of Opioid Withdrawal

approval for this version to be published. Disclosures Joseph V. Pergolizzi Jr., Hani Annabi, Christopher Gharibo, and Jo Ann LeQuang have nothing to disclose. Compliance with Ethics Guidelines This

Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain

responsibility for the integrity of the work as a whole, and have given their approval for this version to be published. Disclosures. Joseph V. Pergolizzi, Robert Taylor, Jr, Jo Ann LeQuang, Robert B. Raffa, and

Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone/naltrexone extended-release product

Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone/naltrexone extended‑release product Joseph V Pergolizzi, Jr,1 Robert Taylor Jr,1 Jo Ann

The Basic Pharmacology of Opioids Informs the Opioid Discourse about Misuse and Abuse: A Review

Pergolizzi, Robert Raffa, Jo Ann LeQuang and Garrett Berger declare that they have no conflict of interest. Compliance with Ethics Guidelines. This article does not contain any new studies with human or